Joshua N. Silverman
Chairman
TAO Synergies Inc. (TAOX)Board Member
PharmaCyte Biotech, Inc. (PMCB)Chairman
PharmaCyte Biotech, Inc. (PMCB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joshua N. Silverman
Joshua N. Silverman is recorded as CEO, Board Member and Chairman at PharmaCyte Biotech, Inc. (PMCB) and Chairman at TAO Synergies Inc. (TAOX). Earlier roles on record: Chairman at Petros Pharmaceuticals, Inc. (PTPI) until September 30, 2026. Petros Pharmaceuticals, Inc. reported in an 8-K filed September 30, 2026 that Joshua N. Silverman resigned as Executive Chairman, effective September 30, 2026. PharmaCyte Biotech, Inc. reported in an 8-K filed April 2, 2026 that Joshua N. Silverman was appointed Director, effective March 30, 2026. PharmaCyte Biotech, Inc. reported in an 8-K filed October 7, 2022 that Joshua N. Silverman was appointed interim President, effective October 6, 2022. Equibles holds 7 filed executive changes naming Joshua N. Silverman; each is listed under recent activity with its source filing. The proxy statement of PharmaCyte Biotech, Inc. reports total compensation of $520,257 for Joshua N. Silverman in fiscal 2025, including a base salary of $375,000. Disclosed compensation is on record for 4 fiscal years.
“Joshua N. Silverman, Executive Chairman”
“The election of five directors, each to hold office until the annual meeting of stockholders for the year ended April 30, 2027, or until each director's respective successor is elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-03-30–present
-
Current
2022-10-06–present
-
PharmaCyte Biotech, Inc. (PMCB)
SEC 8-K
Current2022-10-06–present
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Start not stated–2026-09-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at PharmaCyte Biotech, Inc.
Other people whose current roles at this company are on record from its filings.
- Joshua Silverman CEO
- Gerald W. Crabtree CTO
- Daniel Allen Board Member
- Jack E. Stover Board Member
- Jonathan L. Schechter Board Member
- Michael M. Abecassis Board Member
- Robert Weinstein Board Member
- Wayne R. Walker Board Member
Leadership on record at TAO Synergies Inc.
Other people whose current roles at this company are on record from its filings.
- Bruce T. Bernstein Chairman
- Joshua Silverman Chairman
- Robert Weinstein CFO
- Alan Tuchman Board Member
- Daniel L. Alkon Board Member
- Jonathan L. Schechter Board Member
- Robert Ephron Board Member
- William S. Singer Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | PharmaCyte Biotech, Inc. (PMCB) | Officer and President | $375,000 | $520,257 |
| 2024 | PharmaCyte Biotech, Inc. (PMCB) | Officer and Interim President | $375,000 | $787,923 |
| 2023 | PharmaCyte Biotech, Inc. (PMCB) | Officer and Interim President | $197,917 | $197,917 |
| 2022 | PharmaCyte Biotech, Inc. (PMCB) | Officer and Interim President | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.